Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, octobre 13
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Processa Pharmaceuticals Inc
PCSA
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$1.77
-0.13
-6.84%
Dern. MÀJ: Oct 13, 5:29 PM
$1.74
-0.16
-8.42%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Privacy Manager
Processa Pharma Financials
Processa Pharma (PCSA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Processa Pharma Q2 EPS $(0.25) Misses $(0.20) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.20) by 25 percent. This is a 75.25 percent increase over losses of $(1.01) per share from
Benzinga Newsdesk
Crude Oil Rises Sharply; Jabil Earnings Top Views
Avi Kapoor
PRO
Processa Pharma Q3 2024 GAAP EPS $(1.03) Misses $(1.00) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent.
Benzinga Newsdesk
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
PRO
Processa Pharma Q2 EPS $(1.01) Beats $(1.02) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.02) by 0.98 percent. This is a 49.5 percent increase over losses of $(2.00) per share from the
Benzinga Newsdesk
Nasdaq Down 1%; JetBlue Airways Shares Spike Higher
Avi Kapoor
